skip to Main Content

Benefit from the Inclusion of Surgery in the Treatment of Patients with Stage III Pancreatic Cancer: a Propensity-Adjusted, Population-Based SEER Analysis

Newsfeed image, light gray text on dark gray background
In the past 20 years, surgical resection has been a secure and applicable procedure for pancreatic cancer (PC), but it remains controversial for stage III PC with data evaluating its efficacy mostly derived from small randomized trials. Hence, we designed this study to further evaluate its benefit using surveillance, epidemiology, and end results dataset.

Patients with stage III PC were identified in the surveillance, epidemiology, and end results registries from 2004 to 2014. The effect of surgery on cancer-specific survival was assessed by risk-adjusted Cox proportional hazard regression modeling and propensity score matching. Read more . . .

Back To Top